Articles dans des revues avec comité de lecture (368)
  1. 46. Fayyad Kazan, H., Fayyad Kazan, M., Merimi, M., Meuleman, N., Bron, D., Lagneaux, L., & Najar, M. (2017). The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation. Cell biology international. doi:10.1002/cbin.10897
  2. 47. Bron, D., & Soubeyran, P. (2017). Rational therapeutic choice for older patients with lymphoma. Current opinion in oncology, 29(5), 322-327. doi:10.1097/CCO.0000000000000394
  3. 48. Chaput, F., Amer, R., Baglivo, E., Touitou, V., Kozyreff, A., Bron, D., Bodaghi, B., LeHoang, P., Bergstrom, C. C., Grossniklaus, H. H., Chan, C.-C., Pe’er, J., & Caspers, L. (2017). Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome. Ocular immunology and inflammation, 25(5), 639-648. doi:10.3109/09273948.2016.1139733
  4. 49. Dosin, G., Aoun, F., El Rassy, E., Assi, T., Lewalle, P., Blanc, J., Van Velthoven, R., & Bron, D. (2017). Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant. Clinical Lymphoma, Myeloma and Leukemia, 17(7), 438-442. doi:10.1016/j.clml.2017.05.013
  5. 50. Springael, C., De Vicq De Cumptich, M., Kolivras, A., & Bron, D. (2017). Nouvelles approches thérapeutiques dans les lymphomes T cutanés. Hématologie, 23(4), 230-235. doi:10.1684/hma.2017.1286
  6. 51. Raicevic, G., Najar, M., Busser, H., Crompot, E., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2017). Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells. Scientific reports, 7(1), 2896. doi:10.1038/s41598-017-02850-6
  7. 52. Crompot, E., Van Damme, M., Pieters, K., Vermeersch, M., Perez-Morga, D., Mineur, P., Maerevoet, M., Meuleman, N., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2017). Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications. Haematologica, 102(9), 1594-1604. doi:10.3324/haematol.2016.163337
  8. 53. Najar, M., Krayem, M., Meuleman, N., Bron, D., & Lagneaux, L. (2017). Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review. Immune network, 17(2), 89-102. doi:10.4110/in.2017.17.2.89
  9. 54. Van Gelder, M., Bron, D., et al. (2017). Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation. Bone marrow transplantation, 52(3), 372-380. doi:10.1038/bmt.2016.282
  10. 55. Fayyad Kazan, M., Fayyad Kazan, H., Merimi, M., Meuleman, N., Bron, D., Lagneaux, L., & Najar, M. (2017). Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures. Data in Brief, 11, 442-445. doi:10.1016/j.dib.2017.02.036
  11. 56. Socié, G., Gard, P., Medeghri, Z., Lehert, P., Lai, C., Corn, T., Vernant, J. P., Vigouroux, S., Yakoub-Agha, I., Bay, J. O., Fürst, S., Bilger, K., Suarez, F., Michallet, M., & Bron, D. (2017). A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood, 129(5), 643-649. doi:10.1182/blood-2016-09-738625
  12. 57. Bron, D., Bosly, A., Coiffier, B., Aurer, I., André, M., Bonnet, C., Caballero, D., Falandry, C., Kimby, E., Soubeyran, P., & Zucca, E. (2017). Unmet needs in the scientific approach to older patients with lymphoma. Haematologica, 102(6), 972-975. doi:10.3324/haematol.2017.167619
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>